Mississippi Cannabis Legislation

SB2117 revises Mississippi's Uniform Controlled Substances Act, removing cannabis from Schedule I, which allows for the state's medical cannabis program to operate.

HB895 eliminated mandatory follow-up visits and extended medical cannabis certification and ID card validity to 24 months for Mississippi patients.

HB1152 created a "Right to Try" for terminally ill patients to use medical cannabis, expanding access beyond the state's existing program.

HB417 added five substances to Schedule I of Mississippi's Uniform Controlled Substances Act, impacting criminal penalties for possession and distribution.

SB2107 revised Mississippi's aggravated trafficking law by adding a dosage element, impacting sentencing for drug offenses and potentially affecting defendants and the justice system.

HB1034 allowed terminally ill patients to use medical cannabis in hospitals, impacting patient access and hospital policy in Mississippi.

HB513 diverted a percentage of Medical Cannabis Act funds to the Public Health Trust Fund for four years, impacting state health initiatives and the cannabis program's financial structure.

SB3318 would have allocated state funds to the University of Mississippi for medical cannabis research, impacting future patient access and product development.

SB3320 appropriated funds to Mississippi's Medical Cannabis Advisory Committee for FY2027, impacting the committee's ability to operate and advise on patient access and program development.

HB1711 allowed Mississippi medical cannabis dispensaries to sell directly to designated caregivers without the patient present, simplifying access for homebound or incapacitated patients.

HB1753 aimed to amend Mississippi's medical cannabis act, potentially impacting patient access, product availability, or business operations.

HB1195 prohibited all advertising and marketing of medical cannabis in Mississippi, impacting patient access to product information and operator's ability to promote their businesses.

SB2455 removed potency limits for cannabis flower, trim, tinctures, oils, and concentrates, impacting patient access to higher potency products in Mississippi.

HB894 removed THC potency limits for medical cannabis concentrates, impacting patients' access to higher potency products in Mississippi.

SB2438 allowed medical cannabis use in Mississippi when conventional treatments failed, impacting patients seeking alternative care.

SB2546 eliminated required follow-up visits and extended medical cannabis certification and ID card validity, easing patient access in Mississippi.

HB1773 extended the repealer on Mississippi's Medical Cannabis Advisory Committee, impacting patient advocacy and program oversight.

SB2540 aimed to update Mississippi's hemp cultivation laws, impacting farmers and the state's hemp industry by clarifying regulations.

SB2220 would have legalized marijuana in Mississippi, impacting consumers, patients, and potential operators by establishing a regulated market.

HB864 failed, meaning kratom remains unscheduled and accessible to consumers in Mississippi, avoiding a Schedule I ban.

HB1590 created the Mississippi Uniform Controlled Substance Analog Act, classifying certain cannabis-derived products as Schedule I controlled substances, impacting consumers and the medical cannabis program.

HB1768 extended sunset clauses for DOH/DOR exemptions under the MS Medical Cannabis Act, impacting regulatory stability for patients and operators.

SB2572 would have legalized the manufacture and sale of hemp beverages in Mississippi, impacting consumers and the nascent hemp industry.

HB1267 authorized and regulated personal use marijuana in Mississippi, impacting consumers and the public by establishing a legal framework.

SB2085 would have reduced penalties for marijuana and synthetic cannabinoid possession, impacting Mississippians with certain convictions.

SB2218 would have reduced penalties for simple cannabis possession in Mississippi, impacting consumers and the public by lessening potential legal repercussions.

HB1430 authorized a civil penalty for possessing less than 3.5 ounces of marijuana, impacting consumers by potentially reducing criminal charges in Mississippi.

HB1431 authorized "time served" for cannabis possession under 3.5 ounces, offering relief to Mississippians with minor marijuana offenses.

HB196 would have replaced criminal penalties with civil fines for marijuana possession in Mississippi, impacting consumers and the justice system.

HB1280 reduced penalties for cannabis possession in Mississippi, which would have lessened legal burdens for consumers and the public.

SB2229 made possession of 30 grams or less of marijuana a civil infraction in Mississippi, shifting from criminal penalties for consumers.

HB199 would have replaced criminal penalties with civil fines for possessing small amounts of cannabis in Mississippi, impacting consumers and the justice system.

SB2095 would have prevented warrantless searches based solely on marijuana odor, protecting Mississippians from intrusive law enforcement practices.

HB448 excluded hypodermic syringes from paraphernalia, impacting public health and drug policy by potentially reducing harm for people who use drugs in Mississippi.

SB2645 prohibited the sale of beverages containing hemp, THC, or kratom in Mississippi, impacting consumer access and the state's emerging cannabis and kratom markets.